A new study revealed safe MS treatment options during pregnancy, reassuring women to balance effective care with their plans ...

Santhera has begun launch preparations for AGAMREE® in UK with first sales expected in this quarterPratteln, Switzerland, January 16, 2025 – ...

These launches belong to what Oelrich called “must-win battles” at Bayer as Xarelto loss of exclusivity reaches “full swing” ...

Acadia Pharmaceuticals ACAD announced that it has submitted a marketing authorization application (MAA) to the European ...

Eli Lilly has received approval from the US Food and Drug Administration (FDA) for Omvoh (mirikizumab-mrkz) to treat ...

Treating the growing problem of childhood obesity calls for exploring new approaches and treatments through well-designed ...

The UK’s health technology assessor, the National Institute for Health and Care Excellence (NICE) has issued positive Final Guidance that recommends Agamree (vamorolone) for use in the National Health ...

Dimerix has achieved a key milestone in its ACTION3 phase III trial of lead asset DMX-200 into focal segmental ...

Acadia Pharma seeks European marketing approval for trofinetide for the treatment of Rett syndrome: San Diego Thursday, January 16, 2025, 13:00 Hrs [IST] Acadia Pharmaceuticals In ...

AGAMREE® is a trademark of Santhera Pharmaceuticals.

The government is urging the public to get vaccinated against influenza and Covid-19 before the Lunar New Year holiday, which ...

Achieving global regulatory harmonization for biosimilar vaccines and immunotherapies is essential to improving market access ...